Biotech · Private company · Nashville, TN, US

Revance Therapeutics, Inc.

SEC CIK 0001479290

Track this companyFree. Adds Revance Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials202 recruiting or active

Pipeline programs17From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline17

Botulinum Toxins, Type APhase 3 · Glabellar Frown LinesClinicalTrials.gov · fetched Nov 12, 2026
DaxibotulinumtoxinA for injectionPhase 3 · Cervical DystoniaClinicalTrials.gov · fetched Nov 12, 2026
Botulinum Toxin Type APhase 2 · Lateral Canthal LinesClinicalTrials.gov · fetched Nov 12, 2026
Botulinum Toxins, Type APhase 2 · Plantar FasciitisClinicalTrials.gov · fetched Nov 12, 2026
DAXI 120 UPhase 2 · Plantar FasciitisClinicalTrials.gov · fetched Nov 12, 2026
DAXI 80 UPhase 2 · Plantar FasciitisClinicalTrials.gov · fetched Nov 12, 2026
DAXI for injection 250 UPhase 2 · Upper Limb SpasticityClinicalTrials.gov · fetched Nov 12, 2026
DAXI for injection 375 UPhase 2 · Upper Limb SpasticityClinicalTrials.gov · fetched Nov 12, 2026
DAXI for injection 500 UPhase 2 · Upper Limb SpasticityClinicalTrials.gov · fetched Nov 12, 2026
daxibotulinumtoxin type APhase 2 · Plantar FasciitisClinicalTrials.gov · fetched Nov 12, 2026
DaxibotulinumtoxinAPhase 2 · Torticollis (Spasmodic)ClinicalTrials.gov · fetched Nov 12, 2026
DaxibotulinumtoxinA for injectionPhase 2 · Lateral Canthal LinesClinicalTrials.gov · fetched Nov 12, 2026
DaxibotulinumtoxinA for injectionPhase 2 · Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)ClinicalTrials.gov · fetched Nov 12, 2026
DaxibotulinumtoxinA for injectionPhase 2 · Frown LinesClinicalTrials.gov · fetched Nov 12, 2026
DAXXIFYPhase 2 · Glabellar Frown LinesClinicalTrials.gov · fetched Nov 12, 2026
RT001 (Botulinum Toxin Type A Topical Gel)Phase 2 · Lateral Canthal LinesClinicalTrials.gov · fetched Nov 12, 2026
Vehicle ControlPhase 2 · Lateral Canthal LinesClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials20

DaxibotulinumtoxinA for BlepharospasmPHASE2 · RECRUITING · started Sep 24, 2026ClinicalTrials.gov NCT07489430 · fetched Nov 12, 2026
Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial SpasmPHASE4 · RECRUITING · started Feb 11, 2025ClinicalTrials.gov NCT06195241 · fetched Nov 12, 2026
Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar LinesPHASE2 · COMPLETED · started Apr 8, 2024ClinicalTrials.gov NCT06411002 · fetched Nov 12, 2026
An Open Label, Study of DaxibotulinumtoxinA for Migraine PreventionUNKNOWN · started Oct 24, 2023ClinicalTrials.gov NCT06154070 · fetched Nov 12, 2026
Open Label, 6-month Study for High Frequency and Chronic Migraine,UNKNOWN · started Oct 18, 2023ClinicalTrials.gov NCT06133491 · fetched Nov 12, 2026
Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial LinesPHASE2 · COMPLETED · started Dec 6, 2019ClinicalTrials.gov NCT04259086 · fetched Nov 12, 2026
Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal LinesPHASE2 · COMPLETED · started Mar 11, 2019ClinicalTrials.gov NCT03911102 · fetched Nov 12, 2026
Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)PHASE2 · COMPLETED · started Jan 24, 2019ClinicalTrials.gov NCT03786770 · fetched Nov 12, 2026
DaxibotulinumtoxinA for Injection for the Treatment of Plantar FasciitisPHASE2 · COMPLETED · started Dec 31, 2018ClinicalTrials.gov NCT03825315 · fetched Nov 12, 2026
Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb SpasticityPHASE2 · COMPLETED · started Dec 12, 2018ClinicalTrials.gov NCT03821402 · fetched Nov 12, 2026
Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)PHASE3 · COMPLETED · started Sep 5, 2018ClinicalTrials.gov NCT03617367 · fetched Nov 12, 2026
Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)PHASE3 · COMPLETED · started Jun 20, 2018ClinicalTrials.gov NCT03608397 · fetched Nov 12, 2026
Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar FasciitisPHASE2 · COMPLETED · started Jun 12, 2017ClinicalTrials.gov NCT03137407 · fetched Nov 12, 2026
Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar LinesPHASE3 · COMPLETED · started Dec 9, 2016ClinicalTrials.gov NCT03004248 · fetched Nov 12, 2026
Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesPHASE3 · COMPLETED · started Dec 8, 2016ClinicalTrials.gov NCT03014622 · fetched Nov 12, 2026
Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesPHASE3 · COMPLETED · started Dec 5, 2016ClinicalTrials.gov NCT03014635 · fetched Nov 12, 2026
DaxibotulinumtoxinA for Injection for the Management of Plantar FasciitisPHASE2 · TERMINATED · started Nov 14, 2016ClinicalTrials.gov NCT02973269 · fetched Nov 12, 2026
Dose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical DystoniaPHASE2 · COMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT02706795 · fetched Nov 12, 2026
Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in AdultsPHASE2 · COMPLETED · started Jan 1, 2010ClinicalTrials.gov NCT01064518 · fetched Nov 12, 2026
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal LinesPHASE2 · COMPLETED · started Feb 1, 2009ClinicalTrials.gov NCT00884234 · fetched Nov 12, 2026

SEC filings9

8-K · 8-KSEC EDGAR · filed Feb 6, 2025 · fetched Nov 12, 2026
8-K · FORM 8-KSEC EDGAR · filed Jan 21, 2025 · fetched Nov 12, 2026
8-K · FORM 8-KSEC EDGAR · filed Dec 12, 2024 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Dec 9, 2024 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Dec 5, 2024 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Dec 3, 2024 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Nov 29, 2024 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Nov 26, 2024 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Nov 19, 2024 · fetched Nov 12, 2026